{"id":"NCT02452060","sponsor":"NYU Langone Health","briefTitle":"Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy","officialTitle":"Randomized, Double-blind, Placebo Controlled Study on the Effect of a Single Postoperative Administration of Low Dose Ketamine After Gastric Bypass and Gastrectomy Surgeries","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2014-10","primaryCompletion":"2017-04-13","completion":"2017-04-13","firstPosted":"2015-05-22","resultsPosted":"2020-03-16","lastUpdate":"2020-03-16"},"enrollment":90,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Postoperative Depression"],"interventions":[{"type":"DRUG","name":"Ketamine","otherNames":["ketalar"]},{"type":"OTHER","name":"Placebo Comparator","otherNames":["Saline Infusion"]}],"arms":[{"label":"treatment/placebo","type":"PLACEBO_COMPARATOR"},{"label":"treatment","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.","primaryOutcome":{"measure":"Change in Pain Scores","timeFrame":"Baseline (DOS) to 7 days (Post Op)","effectByArm":[{"arm":"Treatment/Placebo","deltaMin":1.45,"sd":0.23},{"arm":"Treatment","deltaMin":1,"sd":0.18}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["30095550"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":46},"commonTop":["dizziness/lightheadedness","nausea","euphoria","visual hallucination","Dysphoria"]}}